(PHILADELPHIA) - Eydie Miller-Ellis, MD, professor of Clinical Ophthalmology and director of the Glaucoma Division at Scheie Eye Institute, was recently presented with the Women in Ophthalmology’s Suzanne Veronneau Troutman Award at the 2011 American Academy of Ophthalmology meeting. The honor recognizes the woman, nominated by the WIO membership, who has done the most over the past year to further women in ophthalmology.
“I’m honored to accept such a prestigious award,” said Dr. Miller. “To be recognized by my peers, whose work I respect and admire so much, means a great deal. It is my privilege to mentor women in ophthalmology and hopefully foster future generations of researchers this field.”
Women In Ophthalmology was founded to enhance and improve the professional environment for women ophthalmologists. WIO encourages diversity, impartiality, and economic parity, and strives to cultivate new opportunities for leadership, education, and public service in the field of ophthalmology for current and future generations.
“Dr. Miller is a pioneer in advancing the involvement of women in ophthalmology on a local and national level,” said Joan O’Brien, MD, Chair, Department of Ophthalmology, Scheie Eye Institute. “She is an extraordinary asset to our Department, and we are honored to work with her. But perhaps even more importantly, her efforts to support the careers of women and minorities in Ophthalmology represents a selfless dedication to mentor and develop diversity in our field. I cannot adequately express my admiration for Dr. Miller-Ellis and her achievements in advancing the careers of others.
Dr. Miller joined the Hospital at the University of Pennsylvania and Scheie Eye Institute in 2001. Dr. Miller's research interests include medical and surgical interventions for glaucoma, and diagnostic techniques for the evaluation of glaucoma. She specializes in the diagnosis and medical/surgical management of complex glaucoma. She also treats patients with glaucoma secondary to other diseases of the eye or systemic disease, as well as patients with both cataracts and glaucoma. Dr. Miller earned her MD from the University of Pittsburgh.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.